503A vs 503B Compounding Pharmacies: Key Differences Explained

Feb 135 min read

Compounding pharmacies aim to provide tailored medications according to the patient's prescriptions. Hence, compounding pharmacies play an essential role in manufacturing customized medications. They are divided into two categories which are 503A and 503B.

These pharmacies prepare medications by mixing, compounding, or altering various drugs according to the patient’s prescriptions. Such medications aim to increase the palatability of the patients by adding flavoring agents, excluding allergens for allergic patients, and adjusting dosage forms to meet patient's requirements.

What Is 503A Compounding Pharmacy?

503A compounding pharmacy is a traditional compounding pharmacy usually managed by state boards that comply with the requirements of USP 797 guidelines. These pharmacies prepare medications according to the individual patient's prescription. These medications must comply with the cGMP regulations to meet the safety and quality standards. These pharmacies have limited use of medications for home use, very small-scale production, etc.

For example, 503A pharmacy prepares customized medication for a patient allergic to a certain ingredient by isolating the active ingredient in a particular drug and stabilizing it with inactive ingredients to which the patient is not allergic.

What Is 503B Compounding Pharmacy?

503B compounding pharmacy, known as 503B outsourcing facility prepares medications with or without prescriptions in large batches to be sold to healthcare facilities and is for office use only. Large-scale production reduces the manufacturing cost and makes the medications affordable for the consumers.

The 503B pharmacies should follow all the cGMP regulations and higher requirements that a large-scale production follows. These drugs should be registered with the FDA but are exempted from the drug approval requirements of the FDA.

Also Read: IND Vs NDA In Pharmacy

Difference Between 503A And 503B Compounding Pharmacy:

The 503A and 503B compounding pharmacies differ from each other in several ways from their primary purpose to various other major factors which are as follows:

Criteria	503A Compounding Pharmacies	503B Compounding Pharmacies
Primary Function	Customized compounding for individual patients	Compounding in bulk for healthcare facilities
Prescription Requirements	Prescription is mandatory	Prescription is not required
Regulatory Body	State Board of Pharmacy	FDA with mandatory compliance to cGMP
Compounding Guidelines	USP <795> for non-sterile and USP <797> for sterile	cGMP and FDA regulations
Labelling Requirements	Minimum labelling	Comprehensive Labelling adhering to the FDA requirements.
Batch Size	Small batches	Large-scale batches
Inspection Frequency	Less frequent inspections	Frequent FDA inspections
FDA Involvement	Lesser direct involvement	Direct involvement of the FDA, product registration required with the FDA.
Distribution Restrictions	Cannot be shipped inter-state	Can be shipped inter-state
Common Users	Individual Patients	Healthcare facilities and hospitals

Also Read: Drugs Vs Medicines

503A Vs 503B Compounding Pharmacies:

The two categories of compounding pharmacy, 503A and 503B are compared on various categories below:

Primary Function:

The primary function of 503A pharmacy is to provide customized compound medications for individual patients while 503B pharmacy aims for bulk manufacturing of compound medications for healthcare facilities.

Prescription Requirements:

Pharmacy 503A dispenses medications only upon prescription while 503B pharmacy manufactures medicines with or without prescriptions.

Regulatory Body:

State Board of Pharmacy regulates the working of 503A while the FDA regulates 503B pharmacies.

Compounding Guidelines:

The USP <795> for non-sterile and USP <797> for sterile provides guideline for compound medicines in 503A pharmacy and FDA provides guidelines for compounding medicines in 503B pharmacy.

Labelling Requirements:

503A compounding pharmacy requires minimum labeling, whereas a 503B compounding pharmacy requires comprehensive labeling complying with the FDA as it involves large-scale production.

Batch Size:

Small batches are involved in 503A pharmacy and 503B involves large scale batches.

Inspection Frequency:

Inspections are not conducted very frequently for 503A pharmacy medications but frequent inspections by the FDA are conducted for medications compounded by 503B pharmacy.

FDA Involvement:

FDA does not have much involvement in the working of 503A pharmacy but has direct involvement with the 503B pharmacy and all the products sold under 503B pharmacy should be registered with FDA.

Distribution Restrictions:

Medications under 503A pharmacy cannot be distributed inter-state whereas 503B pharmacy medications can be distributed inter-state.

Common Users:

The common users of 503A medications are individual patients for whom customized medications are prepared upon prescription while the common users of 503B medications are healthcare facilities including hospitals and clinic for which bulk batches are manufactured.

Similarities Of 503A And 503B Pharmacy:

The key similarities between 503A and 503B pharmacies are:

They both prepare customized medication tailored according to the patient's needs.
They both should comply with FDA regulations.
Both of the pharmacies prepare medications that do not exist in the marketplace.

Regulatory Framework For 503A And 503B Pharmacies:

The FDA released guidelines in October 2017 for the working of 503A and 503B. The guidelines are as follows:

503A:

Must comply with State Board of Pharmacy.
Should also comply with USP <795> and <797> guidelines.
Environmental monitoring should be conducted every six months.
Based on the internal and external scientific stability showing stability Beyond Use Dating (BUD) should be assigned.

503B:

Must comply with State Board of Pharmacy.
Should follow regulations according to the 21 CFR Part 210 and 211 (CGMP)
Organizations are required to register with the State Board of Pharmacy, DEA and the FDA and also submit the product list to the FDA.
In ISO 5 main compounding areas, an environmental monitoring program must be created and carried out at least once every production shift; in ISO 7 and ISO 8 secondary compounding areas, it must be carried out once a week.
Organizations should have their own autonomous quality department.

Is your pharmacy ready to streamline and comply with the regulatory requirements?

So, we at Artixio have expertise in providing tailored solutions for 503A and 503B compounding pharmacies. We help by complying with USP standards meeting FDA cGMP requirements for your compounding product to lead in the market. So, contact today for seamless support.

Benefits Of 503A And 503B Compounding Pharmacy:

503A and 503B compounding medications are found to have innumerous advantages. They are as follows:

503A:

503A compounding medications help provide a personalized experience by providing customized medications according to the patient's requirements.
Changes in dosage quantity can be done according to each patient's requirements.
Medications are prepared very quickly.
These medications are cost effective.

503B:

Bulk quantities of medications can be easily prepared for healthcare facilities.
These compounding pharmacies are overlooked by the FDA, hence high-quality standards are achieved.
These compounding medications are instantly prepared when required by the facilities, meeting their demands.
503B pharmacies make the hospitals stress-free from the in-house compounding of medications for their patients.

503A Vs 503B Compounding Pharmacy Challenges

503A Compounding Pharmacy	503B Compounding Pharmacy
Difficult to comply with both State Board of Pharmacies and FDA regulations for quality and safety.	Challenging to meet all FDA rules and regulations.
Limited to small production capacities.	Difficult to manage large-scale, bulky production.
Requires high skills, knowledge, and specialized equipment for customized medications.	Maintaining high quality in large-scale production is sometimes challenging.
Manufacturing customized medications can be costly.	Frequent inspections may disrupt the manufacturing process.
Insurance may not reimburse compounded medications, making the process difficult.	Managing market competition with large-scale production is challenging.

FAQ’s:

1.What are the two types of compounding pharmacy?

A: 503A and 503B are the two types of compounding pharmacy.

2.What is the difference between a 503A and 503B pharmacy?

A: 503A pharmacy manufactures customized medications on a small scale while 503B manufactures on a large-scale.

3.Can a 503B sell to a 503A?

A: The FDA draft guidance clarified in June 2023 that 503B facilities can sell their compounds to 503A pharmacies.

4. Why is it important to know the stability of a compound preparation? A: It is important to know the stability of the compound preparation for determining the Beyond Use Date (BUD) of the preparation.